Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1

American Journal of Pathology

Volumn 172, Issue 5, 2008, Pages 1297-1302

  Chorny, Alejo ^a   Delgado, Mario ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; UROCORTIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ESCHERICHIA COLI; EX VIVO STUDY; GENE TRANSLOCATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SEPSIS;

EID: 43449087928     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070969     Document Type: Article

References (28)

1. H Wang O Bloom M Zhang JM Vishnubhakat M Ombrellino J Che A Frazier H Yang S Ivanova L Borovikova KR Manogue E Faist E Abraham J Andersson U Andersson PE Molina NN Abumrad A Sama KJ Tracey HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
2. MT Lotze KJ Tracey High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Nat Rev Immunol 5 2005 331 342
3. PL Sappington R Yang H Yang KJ Tracey RL Delude MP Fink HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice Gastroenterology 123 2002 790 802
4. H Yang M Ochani J Li X Qiang M Tanovic HE Harris SM Susarla L Ulloa H Wang R DiRaimo CJ Czura H Wang J Roth HS Warren MP Fink MJ Fenton U Andersson KJ Tracey Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci USA 101 2004 296 301
5. S Qin H Wang R Yuan H Li M Ochani K Ochani M Rosas-Ballina CJ Czura JM Huston E Miller X Lin B Sherry A Kumar G Larosa W Newman KJ Tracey H Yang Role of HMGB1 in apoptosis-mediated sepsis lethality J Exp Med 203 2006 1637 1642
6. E Gonzalez-Rey A Chorny M Delgado Regulation of immune tolerance by anti-inflammatory neuropeptides Nat Rev Immunol 7 2007 52 63
7. WJ Hubbard M Choudhry MG Schwacha JD Kerby LW Rue 3rd KI Bland IH Chaudry Cecal ligation and puncture Shock 24 Suppl 1 2005 52 57
8. JA Buras B Holzmann M Sitkovsky Animal models of sepsis: setting the stage Nat Rev Drug Discov 4 2005 854 865
9. JC Marshall E Deitch LL Moldawer S Opal H Redl T van der Poll Preclinical models of shock and sepsis: what can they tell us? Shock 24 Suppl 1 2005 1 6
10. L Ulloa KJ Tracey The “cytokine profile”: a code for sepsis Trends Mol Med 11 2005 56 63
11. CJ Czura H Yang CA Amella KJ Tracey HMGB1 in the immunology of sepsis (not septic shock) and arthritis Adv Immunol 84 2004 181 200
12. H Wang H Liao M Ochani M Justiniani X Lin L Yang Y Al-Abed C Metz EJ Miller KJ Tracey L Ulloa Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis Nat Med 10 2004 1216 1221
13. L Ulloa M Ochani H Yang M Tanovic D Halperin R Yang CJ Czura MP Fink KJ Tracey Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation Proc Natl Acad Sci USA 99 2002 12351 12356
14. S Gardella C Andrei D Ferrera LV Lotti MR Torrisi ME Bianchi A Rubartelli The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway EMBO Rep 3 2002 995 1001
15. GS Martin DM Mannino S Eaton M Moss The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 348 2003 1546 1554
16. NC Riedemann RF Guo PA Ward The enigma of sepsis J Clin Invest 112 2003 460 467
17. NC Riedemann RF Guo PA Ward Novel strategies for the treatment of sepsis Nat Med 9 2003 517 524
18. B Beutler IW Milsark AC Cerami Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229 1985 869 871
19. KJ Tracey B Beutler SF Lowry J Merryweather S Wolpe IW Milsark RJ Hariri TJ Fahey 3rd A Zentella JD Albert Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470 474
20. E Chatzaki I Charalampopoulos C Leontidis IA Mouzas M Tzardi C Tsatsanis AN Margioris A Gravanis Urocortin in human gastric mucosa: relationship to inflammatory activity J Clin Endocrinol Metab 88 2003 478 483
21. M Kohno Y Kawahito Y Tsubouchi A Hashiramoto R Yamada KI Inoue Y Kusaka T Kubo IJ Elenkov GP Chrousos M Kondo H Sano Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity J Clin Endocrinol Metab 86 2001 4344 4352
22. M Uzuki H Sasano Y Muramatsu K Totsune K Takahashi Y Oki K Iino T Sawai Urocortin in the synovial tissue of patients with rheumatoid arthritis Clin Sci 100 2001 577 589
23. A Gravanis AN Margioris The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications Curr Med Chem 12 2005 1503 1512
24. P Brandtzaeg O Oktedalen P Kierulf PK Opstad Elevated VIP and endotoxin plasma levels in human gram-negative septic shock Regul Pept 24 1989 37 44
25. M Delgado C Abad C Martinez MG Juarranz A Arranz RP Gomariz J Leceta Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases J Mol Med 80 2002 16 24
26. M Delgado C Martinez D Pozo JR Calvo J Leceta D Ganea RP Gomariz Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6 J Immunol 162 1999 1200 1205
27. AM Szema SA Hamidi S Lyubsky KG Dickman S Mathew T Abdel-Razek JJ Chen JA Waschek SI Said Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP Am J Physiol Lung Cell Mol Physiol 291 2006 L880 L886
28. C Martinez C Abad M Delgado A Arranz MG Juarranz N Rodriguez-Henche P Brabet J Leceta RP Gomariz Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor Proc Natl Acad Sci USA 99 2002 1053 1058